Literature DB >> 17373839

Comprehensive proteomic analysis of human cervical-vaginal fluid.

Surendra Dasari1, Leonardo Pereira, Ashok P Reddy, John-Edward A Michaels, Xinfang Lu, Thomas Jacob, Archana Thomas, Matthew Rodland, Charles T Roberts, Michael G Gravett, Srinivasa R Nagalla.   

Abstract

Cervical-vaginal fluid (CVF) is a potential rich source of biomarkers for enhancing our understanding of human parturition and pathologic conditions affecting pregnancy. In this study, we performed a comprehensive survey of the CVF proteome in pregnancy utilizing multidimensional liquid chromatography (2D-LC) coupled with mass spectrometry and gel-electrophoresis-based protein separation and identification. In total, 150 unique proteins were identified using multiple protein identification algorithms. Metabolism (32%) and immune response-related (22%) proteins are the major functional categories represented in the CVF proteome. A comparison of the CVF, serum, and amniotic fluid proteomes showed that 77 proteins are unique to CVF, while 56 and 17 CVF proteins also occur in serum and amniotic fluid, respectively. This data set provides a foundation for evaluation of these proteins as potential CVF biomarkers for noninvasive diagnosis of pregnancy-related disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17373839     DOI: 10.1021/pr0605419

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  46 in total

1.  Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery.

Authors:  Roberto Romero; Shali Mazaki-Tovi; Edi Vaisbuch; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Ricardo Gomez; Jyh Kae Nien; Bo Hyun Yoon; Moshe Mazor; Jingqin Luo; David Banks; John Ryals; Chris Beecher
Journal:  J Matern Fetal Neonatal Med       Date:  2010-05-26

2.  Proteomes of the Female Genital Tract During the Oestrous Cycle.

Authors:  Clement Soleilhavoup; Cindy Riou; Guillaume Tsikis; Valerie Labas; Gregoire Harichaux; Philippa Kohnke; Karine Reynaud; Simon P de Graaf; Nadine Gerard; Xavier Druart
Journal:  Mol Cell Proteomics       Date:  2015-10-30       Impact factor: 5.911

3.  The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-amniotic inflammation is not superior to amniotic fluid interleukin-6.

Authors:  Roberto Romero; Nicholas Kadar; Jezid Miranda; Steven J Korzeniewski; Alyse G Schwartz; Piya Chaemsaithong; Wade Rogers; Eleazar Soto; Francesca Gotsch; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-12-16

Review 4.  Proteomics of the human placenta: promises and realities.

Authors:  J M Robinson; W E Ackerman; D A Kniss; T Takizawa; D D Vandré
Journal:  Placenta       Date:  2008-01-28       Impact factor: 3.481

Review 5.  Vaginal drug delivery systems for HIV prevention.

Authors:  Lisa Cencia Rohan; Alexandra B Sassi
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

6.  Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin.

Authors:  Jutamas Shaughnessy; Lisa A Lewis; Hanna Jarva; Sanjay Ram
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

7.  Noninvasive diagnosis of intraamniotic infection: proteomic biomarkers in vaginal fluid.

Authors:  Jane Hitti; Jodi A Lapidus; Xinfang Lu; Ashok P Reddy; Thomas Jacob; Surendra Dasari; David A Eschenbach; Michael G Gravett; Srinivasa R Nagalla
Journal:  Am J Obstet Gynecol       Date:  2010-05-15       Impact factor: 8.661

8.  Global report on preterm birth and stillbirth (2 of 7): discovery science.

Authors:  Michael G Gravett; Craig E Rubens; Toni M Nunes
Journal:  BMC Pregnancy Childbirth       Date:  2010-02-23       Impact factor: 3.007

9.  Characterization of the Human Cervical Mucous Proteome.

Authors:  Gitika Panicker; Yiming Ye; Dongxia Wang; Elizabeth R Unger
Journal:  Clin Proteomics       Date:  2010-03-09       Impact factor: 3.988

10.  Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins.

Authors:  Sylvette Bas; Richard W James; Cem Gabay
Journal:  BMC Immunol       Date:  2010-09-16       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.